AbCellera Biologics (ABCL) Insider Trading & Ownership $3.07 -0.07 (-2.36%) As of 12:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AbCellera Biologics (NASDAQ:ABCL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.00%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$18.23 MNumber OfInsiders Selling(Last 3 Years)0 Get ABCL Insider Trade Alerts Want to know when executives and insiders are buying or selling AbCellera Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ABCL Insider Buying and Selling by Quarter AbCellera Biologics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/26/2023Andrew BoothCFOBuy14,500$6.85$99,325.00 5/26/2023Holdings Ltd. ThermopylaeMajor ShareholderBuy153,000$6.52$997,560.00 12/16/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy85,102$10.10$859,530.20 8/19/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy200,000$11.46$2,292,000.00 6/13/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy54,915$8.03$440,967.45 6/6/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy64,545$7.50$484,087.50 5/16/2022Veronique LecaultCOOBuy200,000$6.34$1,268,000.00 5/12/2022Andrew BoothCFOBuy85,000$5.79$492,150.00 5/12/2022Holdings Ltd. ThermopylaeMajor ShareholderBuy1,408,468$6.41$9,028,279.88 3/4/2022John S MontalbanoDirectorBuy10,000$8.54$85,400.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/1/2022John S MontalbanoDirectorBuy20,000$9.05$181,000.00 2/28/2022Veronique LecaultCOOBuy230,789$8.66$1,998,632.74 (Data available from 1/1/2013 forward) ABCL Insider Trading Activity - Frequently Asked Questions Who is on AbCellera Biologics's Insider Roster? The list of insiders at AbCellera Biologics includes Andrew Booth, Holdings Ltd. Thermopylae, John S Montalbano, and Veronique Lecault. Learn more on insiders at ABCL. What percentage of AbCellera Biologics stock is owned by insiders? 28.00% of AbCellera Biologics stock is owned by insiders. Learn more on ABCL's insider holdings. Which AbCellera Biologics insiders have been buying company stock? The following insiders have purchased ABCL shares in the last 24 months: Andrew Booth ($99,325.00), and Holdings Ltd. Thermopylae ($997,560.00). How much insider buying is happening at AbCellera Biologics? Insiders have purchased a total of 167,500 ABCL shares in the last 24 months for a total of $1,096,885.00 bought. AbCellera Biologics Key ExecutivesDr. Carl L.G. Hansen Ph.D. (Age 49)CEO, President & Chairperson Compensation: $714.94kMr. Andrew Booth M.B.A. (Age 50)Chief Financial Officer Compensation: $674.55kDr. Veronique Lecault Ph.D. (Age 39)COO & Director Compensation: $650.59kMr. Tryn T. Stimart Esq. (Age 54)J.D., M.Sc., Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer Compensation: $667.69kMarcie Thiessen CPACGA, Senior Director of Finance & AccountingDr. Ester Falconer Ph.D. (Age 49)Chief Technology Officer Kathleen Reid B.A.Head of Corporate CommunicationsGraham Craig M.Sc.Director of Corporate DevelopmentMr. Murray McCutcheon Ph.D.Senior Vice President of PartneringMr. Neil Aubuchon B.A. (Age 54)M.B.A., Chief Commercial Officer Compensation: $684.81k More Insider Trading Tools from MarketBeat Related Companies RNA Insider Ownership ADMA Insider Ownership ACLX Insider Ownership AKRO Insider Ownership RYTM Insider Ownership SRRK Insider Ownership IMVT Insider Ownership APLS Insider Ownership VKTX Insider Ownership ACAD Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:ABCL) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbCellera Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbCellera Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.